Emergency physician judgment on chest pain patients syncs with their outcomesAugust 05, 2009DURHAM, N.C. -- Emergency physicians should trust their judgment when evaluating patients who report with chest pain symptoms, said a group of researchers led by Abhinav Chandra, M.D., at Duke University Medical Center. Their research suggests that emergency physicians should counsel with other physicians against discharge when they feel strongly about a patient for whom there is no compelling data, other than our evaluation and judgment, Chandra said. "There is evidence for emergency room physicians to trust their gut instinct when they have to make a quick decision about a potential heart patient, before lab results are even returned," said Chandra, director of acute care research and of the clinical evaluation unit in the Duke Division of Emergency Medicine. "Sometimes these patients could be better served by staying at the hospital and having more tests rather than being treated and released or discharged." Chandra is lead author of a study on the topic published in the August issue of Academic Emergency Medicine. Examining a robust database, Chandra and the research team found that for patients who lacked obvious initial evidence of a cardiac event, the emergency physicians' estimates of risk in the first 30 days correlated with their actual outcomes. The patients were from nine hospitals, including two non-teaching hospitals and a hospital in Singapore. The data was collected between June 1999 and August 2001. "Based on these data, I believe significant advances in both optimal patient care and cost-effective patient management can result from improved and increased communication between emergency room physicians and admitting physicians," Chandra said. "Our primary concern has to be a central focus on making the best possible decision about which patients should stay, and which should go home, and continually analyzing the factors that would lead to either approach. "Sometimes the initial tests don't indicate anything serious, but I think, based on my experience and the sum of my judgment, there is something more," he said. "I was curious and wondered if I might be out of line or if there would be validity in this gut instinct in emergency physicians. I recalled the existing data from a large registry on coronary outcomes and learned that we could answer the question with evidence." "I was surprised by the magnitude of the good instincts," Chandra said. "Of the 10,713 patients who met the criteria for our study, 604 were diagnosed with unstable angina. A total of 133, or 22 percent, had an adverse outcome in the first 30 days. I think that is pretty substantial." Adverse outcomes included death, heart attack (myocardial infarction), or the need to open blood vessels for blood flow (revascularization). Likewise, Chandra and colleagues evaluated data on the 24 subjects who were discharged from the emergency department who had major adverse cardiac events. A total of 524 were discharged to home from the group assessed as high risk, and five had a major adverse outcome within 30 days. "While only 1 percent had a bad outcome in the first 30 days, that is unsettling, because we see them and express concern about their risk level, yet so many are sent home. We don't know what influenced the ultimate decision by the admitting or ER doctor to send the patients home, and that would be an important variable to study further." Chandra says he hopes to share these findings with a wide group of physicians, "because we all have the same goal of keeping our patients healthy." One way to formalize the value of the gut instinct about chest pain patients would be to introduce objective tools, like those that already exist for risk stratification of patients with pneumonia and for venous thrombus embolism. For example, the emergency physician could use an objective tool to categorize a patient with potential acute coronary syndrome and then add his/her judgment and determine the final probability of ACS, the authors noted. The gut instinct is so important that many emergency medicine residency programs make developing sound medical judgment a formal goal. Chandra said that good independent judgment takes experience to attain, but thinks it begins to be very sound about 1-2 years after formal training ends. "Emergency medicine is unique in that you have a very limited amount of time and data to make decisions," Chandra said. "Emergency physicians are very good at operating under these circumstances." Chandra said the findings are important in today's health care climate. "When we examine cost and efficiency of health care, I think that emergency physicians can make an impact. If we release patients who end up needing further care, costs go up," he said. "Our decisions are better than we might give ourselves credit for." Duke University Medical Center |
|||||||||||||||||||||
| Related Chest Pain Current Events and Chest Pain News Articles Reflux esophagitis due to immune reaction, not acute acid burn, UT Southwestern researchers report Contrary to current thinking, a condition called gastroesophageal reflux disease (GERD) might not develop as a direct result of acidic digestive juices burning the esophagus, UT Southwestern Medical Center researchers have found in an animal study. Your Own Stem Cells Can Treat Heart Disease The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in less pain and an improved ability to walk. The transplant subjects also experienced fewer deaths than those who didn't receive stem cells. Vitamin B niacin offers no extra benefit to statin therapy in seniors already diagnosed with CAD The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows. Elevated biomarkers lead to diminished quality of life in heart attack patients post-discharge Many heart attack patients have high levels of cardiac biomarkers in the blood for several months after leaving the hospital, with more shortness of breath and chest pain, according to a Henry Ford Hospital study. oo much selenium can increase your cholesterol A new study from the University of Warwick has discovered taking too much of the essential mineral selenium in your diet can increase your cholesterol by almost 10%. Some chest pain patients wait longer than 10 minutes to see ER physician Emory University Rollins School of Public Health researchers will present Nov. 10 on a range of topics at the American Public Health Association's annual meeting in Philadelphia, including a study that examined compliance with national recommendations that a physician screen chest pain patients within 10 minutes of their arrival to the Emergency Department (ED). The heart attack myth: Study establishes that women do have same the heart attack symptoms as men The gender difference between men and women is a lot smaller than we've been led to believe when it comes to heart attack symptoms. Angina in the legs? Time to alert patients and physicians Edmonton researchers recommend that people over age 40 be screened for peripheral artery disease (PAD), which puts people at high risk for serious medical complications including heart disease, stroke, and possible lower limb amputation. Study finds partner abuse leads to wide range of health problems Women abused by intimate partners suffer higher rates of a wide variety of doctor-diagnosed medical maladies compared to women who were never abused, according to a new study of more than 3,000 women. Drug-eluting stents better than bare-metal stents for heart attack patients Late-breaking data from the landmark HORIZONS-AMI clinical trial, presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, demonstrated that after two years, in heart attack patients, the use of a drug-eluting stent (paclitaxel) was safer and more effective than a bare-metal stent; and that the administration of the anticoagulant medication bivalirudin enhanced safety and efficacy compared to the use of heparin + GPIIb/IIIa inhibitors. More Chest Pain Current Events and Chest Pain News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||